Alza Drops Patent Suit Over ADHD Drug
Alza filed the lawsuit after Impax sought permission from the U.S. Food and Drug Administration to make a generic version of the drug Concerta. Impax said Alza’s patents for the drug aren’t valid.
The dismissal came as a surprising reversal for Alza’s parent company, J&J. The health care giant filed the lawsuit in September 2005 in...
To view the full article, register now.